Black Rock Inc. Pacira Bio Sciences, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,905,156 shares of PCRX stock, worth $224 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,905,156
Previous 8,114,251
2.58%
Holding current value
$224 Million
Previous $274 Million
15.63%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding PCRX
# of Institutions
286Shares Held
48.7MCall Options Held
156KPut Options Held
623K-
Vanguard Group Inc Valley Forge, PA5.11MShares$145 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.91MShares$54.3 Million0.55% of portfolio
-
State Street Corp Boston, MA1.9MShares$54 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.88MShares$53.4 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$46.2 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.3B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...